FDA Investigator Sunitha K Rajaram, PhD

Sunitha K Rajaram, PhD has inspections in 10 countries as of 22 Sep 2023. Sunitha K Rajaram, PhD has collaborated with a combinined 5509 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
226
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Lithuania, Poland, India, Singapore, China, Dominican Republic, France, Romania, Italy
Co-Investigator(s):
A Williams, Abby M Miller, Ademola O Daramola, Alan D Grupe, Albert F Peacock, PhD, Albert Rodriguez, Alexander M Kay, Alexandria L Capuano, Alicia M Mozzachio, Allen F Hall, Anderson, Andrace Lde Yampert, Andrew K Haack, PhD, Andrew R Wasko, Angel F Colon, Angela Shepas, Anita Narula, PhD, Annette L Diggs, Anthony E Keller, RPh, Ariel Cruz Figueroa, Armando Chavez, MS, Arsen Karapetyan, Astrida B Mattson, Azza Talaat, Barbar J Breithaupt, Barbara J Rincon, Barbara Janine Breithaupt, Barbara T Carmichael, Beau R Lamb, Binh T Nguyen, Blondell W Johnson, Bobbi J Miller, Bonnie I Needleman, Brenda K Alford, Bruce R Burrell, Bryan Baker, Bryce E Mansfield, Camille Bennett Hoffman, Carl A Anderson, Carla J Lundi, Carol A Gripp, Caryn M Mcnab, Celena Ngo, Charles L Larson, Charles R Bonapace, PhD, Cheryl D Mccall, Christopher D Rush, Christopher J Smith, Christopher R Czajka, Christopher W Buser, Connie L Hannon Rabel, Connie P Rezendes, Courtney N Long, Courtney R Bratina, Craig A Garmendia, Ct Viswanathan, PhD, Cynthia J Lee, MS, Cynthia L Gorveatt, Da Lin Yao, MD, PhD, Dan G Eisenbrey, Dandan Wang, PhD, Daniel L Aisen, Darla J Christopher, David L Hunsaker, Dawn E Barkans, Deborah A Greco, Deborah A Nebenzahl, Deborah Kleinfeld, Deborah S Hammond, Debra L Curtis, Decarlos A Gomez, Deniza Karacic, Dennis G Kawabata, Dennis M Farley, Devon M Shoop, Diane Cvan Leeuwen, Diane Hall, Dianna D Wardlow Dotter, Dirk L Lincoln, Dolores E Price, Don H Bark, PhD, Donald B Mckechnie, Donald W Jehn, Dongping Dai, PhD, Donna Ltartaglino Besone, Donna Mwilliams Hill, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Edward D Harris, Emily S Mcgann, Eric L Scott, Erin M Mcdowell, Ernest Serna, III, Farhana Khan, Finn A Slizza, Frans E Mercado, Garrad R Poole, Gerard Pde Leon, Gina C Collins, Gloria A Milster, Gloria J Baca, MS, Grace P Santos, Hanna L Potter, Harmon M Blanch, Harperd, Hasan A Irier, PhD, Heika R Bounds, Heika R Tait, Helen Verdel, Himanshu Gupta, PhD, Hugh Grimoldby, Hugh M Mcclure, II, Iris C Macinnes, Isaiah D Isakson, Ismael Olvera, IV, Jacqueline A O'shaughnessy, PhD, James P Stallings, James R Fleckenstein, James S Cartwright, James S Stuart, BS, Jane M Kreis, Janet B Abt, Janet Pulver, Janice K Pohlman, MD, MPH, Jason T Lovelady, Jason W Cornell, Jean Brewer, Jeanne J Thai, Jeanne M Weishaar, Jeffrey N Gerdes, Jen Sui, Jennifer C Adams, Jennifer M Gogley, Jinkee Mvila Binayug, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, John A Iwen, Jonathan R Campos, Jonathan T Little, Jose R Hernandez, Juanita Banuelos, Judy Ellen Ciaraldi, Julian C Hanson, Ka L Wong, Kaarin M Slotte, Kari M Johansen, Karlton T Watson, Katharine Chan, Katherine E Jacobitz, Katherine L Arnold, Kathleen B Swat, Kathryn A Krentz, Kelley, Kelly D Moore, Kelsey M Bishop, Kenneth L Smalls, Kenneth S Boehnen, Kevin N Tran, Kham Phommachanh, Kimberly A Dux, Kimberly J Proctor Jones, Kirtida Patel, Lakecha N Lewis, Lance W Bohm, Lauren E Swantko, Laurimer Kuilan Torres, Lawrence Y Lee, PhD, Leonard H Lavi, Lequita M Mayhew, Lesley A Swanson, Lillie M Young, Linda Linhn Adams, Linda S Leja, Linda Thai, Lisa K Capron, Lisa R Jennings, Lori A Gioia, Lori J Silverstein, Lorie S Hannappel, Lorna F Jones, Lourdes R Genera, Lynda L Lanning, Lynda L Perry, PhD, Maira P Brading, Marcus F Yambot, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Marion W Nadeau, Mark C Saale, Mark E Imsland, Mark W Babbitt, Marlo Ianm Alintanahin, Marsha L Mccauley, Mary E Baker Brown, Mary T Carden, Maxine H Wong, Maxyne T Lam, Melissa D Kalik, Michael D Garcia, Michael F Schuette, Michael F Skelly, PhD, Michael S Araneta, Michael S Valenzuela, Michelle Y Clark Stuart, Mikel T Wright, Minh D Phan, Mohsen Rajabi Abhari, FDA, Namcy E Byerly, Nancy A Saxenian Emmons, Nancy E Byerly, Nancy T Waites, Neil J Traaen, Nicola M Fenty Stewart, Nicole E Knowlton, Nicole M Bell, Norman Wong, Parul M Patel, Patricia M Jacobs, Paul M Chefor, Paul M Kawamoto, Paula A Trost, Pauline N Logan, Peter C Chow, Peter Kessler, PhD, Peter T Regan, Philip E Ake, Phillip D Kronstein, Prabhu P Raju, Raymond W Brullo, Rebecca A Sletner, Rebecca T Davis, Richard G Runyon, Richard T Riggie, Robert D Tollefsen, Robert M Tillman, Rocco C Black, Roger D Gawne, Romeo A De Claro, Ronald E Gill, Ronda R Loyd Jones, Ruben C Ayala, PharmD, S Lori Brown, PhD MPH, Sandra K Wangen, Sangeeta M Khurana, PhD, Sara Jdent Acosta, Savini, Scott A Nabe, Scott B Laufenberg, Scott K Zika, Scott T Ballard, Selene T Torres, Seneca D Toms, Shaquenta Y Perkins, Sharon I Gundersen, Sharon K Thoma, PharmD, Shelagh D Schopen, Shelby N Marler, Shelley H Beausoleil, Sherri N Rohlf, MD, Shuen G Chai, Sonia R Peterson, Sonya L Karsik, Stanley Au, Stanley B Eugene, BS, BME, State Agency, Stephanie A Slater, MS, Stephen R Souza, Stephen T Hansen, Sumit Sen, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tania Y Hall, Teena H Aiken, Terrance L Thomas, Terri L Jones, Thea C Grome, Theressa B Smith, Thomas C Mclean, CFS, Thomas E Friel, Thomas R Beilke, Timothy C Grome, Tonia L Sawyer, Tracy J Washington, Tracy K Li, Tricia S Martinez, Trudy Papson, Trudy R Papson, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), V Teres Speer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Vickie L Anderson, Vitaliy N Guyvan, Vlada Matusovsky, William C Hughes, William J Foust, William S Vitale, Xiaojun Yan, Yaw O Osei, Young M Choi, PhD, Young M Yoon, Yvonne M Larsen, Yvonne T Lacour, Zerita White

Sunitha K Rajaram, PhD's Documents

Publish Date Document Type Title
March, 2014 FDA 483 Response Gilead Sciences Inc. - Form 483R, 2014-03-18
July, 2016 FDA 483 Bioscience Laboratories Inc - Form 483, 2016-07-29
March, 2010 EIR David Scott - EIR, 2010-03-24
January, 2013 EIR Benaroya Research Institute at Virginia Mason - EIR, 2013-01-29
November, 2011 EIR Olympic Ambulance Service, Inc. dba Olympic Oxygen Service - EIR, 2011-11-16
May, 2019 EIR Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb - EIR, 2019-05-15
April, 2021 FDA 483 Innova Medical Group Inc. - Form 483, 2021-04-09
March, 2014 EIR Gilead Sciences Inc. - EIR, 2014-03-06
January, 2014 FDA 483 Ajay Gopal - Form 483, 2014-01-09
December, 2010 FDA 483 Dr. Maki , Jeffrey - Form 483, 2010-12-21
June, 2023 FDA 483 Arizona Center for Reproductive Endocrinology & Infertility - Form 483, 2023-06-28
October, 2012 EIR Perry S. Brown, M.D. - EIR, 2012-10-16
March, 2012 FDA 483 Skin Biology Inc - Form 483, 2012-03-30
July, 2016 EIR Bioscience Laboratories Inc - EIR, 2016-07-29
October, 2012 FDA 483 Perry S. Brown, M.D. - Form 483, 2012-10-16
March, 2010 FDA 483 David Scott - Form 483, 2010-03-24
March, 2016 EIR Madigan Army Medical Center IRB - EIR, 2016-03-22
November, 2018 FDA 483 Heidi J. Gray, M.D. - Form 483, 2018-11-16
November, 2016 FDA 483 Robert B Montgomery MD - Form 483, 2016-11-01
May, 2013 FDA 483 Partner Therapeutics, Inc. - Form 483, 2013-05-24
March, 2010 FDA 483 Response David Scott - Form 483R, 2010-04-06
July, 2014 FDA 483 Hawkins, Douglas, MD - Form 483, 2014-07-02
June, 2016 FDA 483 Cti Biopharma Inc - Form 483, 2016-06-15
November, 2011 FDA 483 Olympic Ambulance Service, Inc. dba Olympic Oxygen Service - Form 483, 2011-11-16
February, 2019 FDA 483 Stuart L. Silverman, MD - Form 483, 2019-02-01
December, 2010 FDA 483 Response Dr. Maki , Jeffrey - Form 483R, 2011-01-10
February, 2011 FDA 483 Quorum Review Inc. - Form 483, 2011-02-28
April, 2016 FDA 483 Edward Kim - Form 483, 2016-04-22
September, 2015 EIR Kowdley, Kris V., M.D. - EIR, 2015-09-29
June, 2017 FDA 483 Jonathan V Wright MD - Form 483, 2017-06-20
June, 2020 FDA 483 Christina S. Baik, M.D. - Form 483, 2020-06-03
March, 2012 EIR Skin Biology Inc - EIR, 2012-03-30
July, 2018 FDA 483 Anna Kostera-Pruszczyk, MD, PhD - Form 483, 2018-07-13
December, 2017 FDA 483 Piotr Leszczynski, M.D. - Form 483, 2017-12-01
September, 2016 EIR Altasciences Preclinical Seattle, LLC - EIR, 2016-09-02
September, 2015 FDA 483 Response Kowdley, Kris V., M.D. - Form 483R, 2015-10-14
October, 2021 FDA 483 Mohammed A. Bari, MD - Form 483, 2021-10-22
May, 2013 EIR Partner Therapeutics, Inc. - EIR, 2013-05-24
March, 2012 FDA 483 Response Skin Biology Inc - Form 483R, 2012-04-11
May, 2023 FDA 483 Tacoma-Pierce County Blood Bank - Form 483, 2023-05-26
July, 2018 FDA 483 Catherine Petit, MD - Form 483, 2018-07-27
August, 2021 FDA 483 Richard F. McGuire, Jr., MD - Form 483, 2021-08-06
May, 2020 EIR Alturas Analytics, Inc. - EIR, 2020-05-05
March, 2022 EIR Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb - EIR, 2022-03-18
August, 2012 EIR University Of Washington Human Subjects Division - EIR, 2012-08-10
May, 2019 FDA 483 Syed Jamal Mustafa, M.D. - Form 483, 2019-05-31
December, 2010 EIR Dr. Maki , Jeffrey - EIR, 2010-12-21
April, 2021 FDA 483 Robin Kroll, M.D. - Form 483, 2021-04-23
July, 2020 FDA 483 George A. Diaz, M.D. - Form 483, 2020-07-17
October, 2019 FDA 483 Stephen A. Tilles, M.D. - Form 483, 2019-10-31
May, 2020 FDA 483 Alturas Analytics, Inc. - Form 483, 2020-05-05
September, 2022 FDA 483 Gulf Coast Regional Blood Center - Form 483, 2022-09-14
June, 2019 FDA 483 Seth M.Pollack, M.D. - Form 483, 2019-06-27
September, 2015 FDA 483 Kowdley, Kris V., M.D. - Form 483, 2015-09-29
October, 2013 EIR Lee, Scott MD - EIR, 2013-10-03
July, 2014 EIR Hawkins, Douglas, MD - EIR, 2014-07-02
November, 2020 EIR Mark A Turner MD - EIR, 2020-11-13
February, 2019 FDA 483 William Y. Park, M.D. - Form 483, 2019-02-27
June, 2019 EIR Aspire Independent Review Board LLC - EIR, 2019-06-13
November, 2016 FDA 483 Shailender Bhatia - Form 483, 2016-11-30
July, 2016 FDA 483 Response Bioscience Laboratories Inc - Form 483R, 2016-08-18
March, 2018 FDA 483 Paul Nghiem - Form 483, 2018-03-16
September, 2016 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2016-09-02
March, 2014 FDA 483 Gilead Sciences Inc. - Form 483, 2014-03-06
October, 2013 FDA 483 Lee, Scott MD - Form 483, 2013-10-03
January, 2013 FDA 483 Benaroya Research Institute at Virginia Mason - Form 483, 2013-01-29
October, 2012 FDA 483 Response Perry S. Brown, M.D. - Form 483R, 2012-10-27
August, 2017 FDA 483 Sibel Blau, M.D. - Form 483, 2017-08-29
November, 2009 FDA 483 CTI Biopharma Corp - Form 483, 2009-11-18
August, 2013 EIR Emerald Kalama Chemical, LLC - EIR, 2013-10-18
December, 2023 FDA 483 American Reproductive Centers - Form 483, 2023-12-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more